We are live on ! Find out more
ASXC

Asensus Surgical, Inc.

Delisted

ASXC was delisted on the 21st of August, 2024.

119 hedge funds and large institutions have $184M invested in Asensus Surgical, Inc. in 2021 Q2 according to their latest regulatory filings, with 43 funds opening new positions, 25 increasing their positions, 26 reducing their positions, and 24 closing their positions.

New
Increased
Maintained
Reduced
Closed

79% more first-time investments, than exits

New positions opened: 43 | Existing positions closed: 24

62% more capital invested

Capital invested by funds: $113M → $184M (+$70.2M)

20% more call options, than puts

Call options by funds: $11.7M | Put options by funds: $9.78M

19% more funds holding

Funds holding: 100119 (+19)

4% less repeat investments, than reductions

Existing positions increased: 25 | Existing positions reduced: 26

50% less funds holding in top 10

Funds holding in top 10: 21 (-1)

Holders
119
Holders Change
+19
Holders Change %
+19%
% of All Funds
2.07%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
43
Increased
25
Reduced
26
Closed
24
Calls
$11.7M
Puts
$9.78M
Net Calls
+$1.95M
Net Calls Change
-$6.11M
Name Holding Trade Value Shares
Change
Change in
Stake
Vontobel Holding
26
Vontobel Holding
Switzerland
$603K +$474K +189,756 New
APP
27
Avantax Planning Partners
Iowa
$601K
Simplex Trading
28
Simplex Trading
Illinois
$463K -$39.8K -15,934 -10%
Jane Street
29
Jane Street
New York
$462K -$724K -289,795 -67%
VF
30
Virtu Financial
New York
$448K +$212K +84,747 +150%
Manulife (Manufacturers Life Insurance)
31
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$422K +$333K +133,252 New
PP
32
Paloma Partners
Connecticut
$419K +$330K +132,227 New
IA
33
Insight Advisors
Pennsylvania
$392K -$127K -50,700 -24%
BCM
34
Bluefin Capital Management
New York
$346K +$273K +109,204 New
BCM
35
Bridgeway Capital Management
Texas
$336K -$437K -175,000 -62%
Citigroup
36
Citigroup
New York
$333K +$234K +93,614 +819%
T. Rowe Price Associates
37
T. Rowe Price Associates
Maryland
$324K -$1.9K -759 -0.7%
VOYA Investment Management
38
VOYA Investment Management
Georgia
$294K +$232K +92,734 New
JP Morgan Chase
39
JP Morgan Chase
New York
$285K +$225K +89,833 New
MIM
40
MetLife Investment Management
New Jersey
$283K +$223K +89,238 New
Principal Financial Group
41
Principal Financial Group
Iowa
$266K +$210K +83,902 New
PFS
42
Prospera Financial Services
Texas
$264K -$146K -58,500 -41%
EBT
43
Enterprise Bank & Trust
Massachusetts
$257K
Invesco
44
Invesco
Georgia
$253K -$17.6M -7,029,526 -99%
MLICM
45
Metropolitan Life Insurance Company (MetLife)
New York
$217K +$171K +68,322 New
TCM
46
Tradewinds Capital Management
Washington
$206K +$144K +57,500 +759%
ProShare Advisors
47
ProShare Advisors
Maryland
$192K +$152K +60,703 New
MIAN
48
Mariner Independent Advisor Network
Kansas
$168K +$132K +52,881 New
Bank of America
49
Bank of America
North Carolina
$151K +$100K +40,208 +552%
RJA
50
Raymond James & Associates
Florida
$149K -$171K -68,569 -59%

ASXC Hedge Fund Activity: Q2 2021 in Review

119 of the 5,746 institutional investors tracked by Wall St. Rank reported a position in Asensus Surgical, Inc. (ASXC) for Q2 2021, worth a combined $184M — up 62% from $113M a quarter earlier.

Buyers outnumbered sellers: 43 funds opened new ASXC positions and 24 closed out — a net gain of 19 holders — while 25 added to existing stakes and 26 trimmed.

The largest buyer was BlackRock, adding an estimated $33M. The largest seller was Invesco, cutting an estimated $17.6M.

  • 119 institutional investors held Asensus Surgical, Inc. (ASXC) as of Q2 2021, up from 100 in Q1 2021.
  • Funds reported $184M of Asensus Surgical, Inc. stock for Q2 2021, up 62% quarter-over-quarter.
  • 43 funds opened new Asensus Surgical, Inc. positions in Q2 2021 and 24 closed out, a net change of +19 holders.
  • The largest Asensus Surgical, Inc. buyer in Q2 2021 was BlackRock, an estimated $33M added.
  • The largest Asensus Surgical, Inc. seller in Q2 2021 was Invesco, an estimated $17.6M sold.

Based on aggregated 13F filings for Q2 2021.